Managed Care Cast

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included CMS Administrator Seema Verma calling for more disruption to the healthcare system; former FDA Commissioner Scott Gottlieb, MD, reflecting on the agency’s record of innovation; liraglutide demonstrating promise for youth with type 2 diabetes.

Read more about the stories in this podcast:

CMS' Verma: Upend the Status Quo to Move to Value-Based Care: https://www.ajmc.com/conferences/naacos-spring-2019/cms-verma-upend-the-status-quo-to-move-to-valuebased-care

National Association of ACOs Spring 2019: https://www.ajmc.com/conferences/naacos-spring-2019

In First Speech Since Stepping Down as FDA Commissioner, Gottlieb Reflects on Agency's Push for Innovation: https://www.ajmc.com/conferences/whcc-2019/in-first-speech-since-stepping-down-as-fda-commissioner-gottlieb-reflects-on-agencys-push-for-innovation

World Health Care Congress 2019: https://www.ajmc.com/conferences/whcc-2019

Liraglutide Lowers A1C in Youth With Type 2 Diabetes, Phase 3 Study Finds: https://www.ajmc.com/focus-of-the-week/liraglutide-lowers-a1c-in-youth-with-type-2-diabetes-phase-3-study-finds/

Study: Oncotype DX-Guided Treatment May Cut Breast Cancer Care Costs by $50 Million in US: https://www.ajmc.com/newsroom/study-oncotype-dxguided-treatment-may-cut-breast-cancer-care-costs-by-50-million-in-us

Why Patients Seek Out Medical Cannabis: https://www.ajmc.com/managed-care-cast/why-patients-seek-out-medical-cannabis

Heard at COA: Improving Cancer Care in Community Practices With OneOncology by Managed Care Cast

Earlier this year a paper published in Health Affairs discussed the reasons why patients seek out medical cannabis. We spoke with one of the authors, Kevin F. Boehnke, PhD, a researcher in anesthesiology, about the findings that chronic pain accounted for the majority of all patient-reported qualifying conditions under which US patients sought medical marijuana.

We also discuss other topics related to medical cannabis in the United States, as well as the kinds of future research that would be helpful to understanding this issue.

Today we’re speaking with Dr. Steven Goldberg, the vice president of medical affairs, population health, and chief health officer at Quest Diagnostics. He is also a co-author of a recent peer-reviewed case study that analyzed a benefits and wellness program designed by a self-insured employer. The employer, Quest Diagnostics, covers nearly 60,000 lives. The analysis of the program showed that it was able to reduce costs while maintaining program quality and promoting population health. According to the study findings, through proactive changes, physician executive leadership, health plan collaboration, disease-specific population health initiatives, and plan design, Quest Diagnostic's annual healthcare cost trend steadily improved from a year-over-year trend of 5.7% from 2014 to 2015, to 4.6% from 2015 to 2016, to -1.0% for 2016 to 2017, and most recently, 0.3% in the 2017 to 2018 year.

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included a study demonstrating that diabetes drug canagliflozin cuts the risk of renal failure and death; the FDA approving the first targeted therapy for metastatic bladder cancer; approximately half of all cancer deaths are attributable to modifiable risk factors.

Read more about the stories in this podcast:

CREDENCE: Canagliflozin Cuts Risk of Renal Failure, Death 30% in Patients With Type 2 Diabetes, CKD: https://www.ajmc.com/newsroom/credence-canagliflozin-cuts-risk-of-renal-failure-death-30-in-patients-with-type-2-diabetes-ckd

FDA Approves Erdafitinib, First Targeted Therapy for Metastatic Bladder Cancer: https://www.ajmc.com/newsroom/fda-approves-erdafitinib-first-targeted-therapy-for-metastatic-bladder-cancer

Nearly Half of Cancer Deaths Attributable to Modifiable Risk Factors: https://www.ajmc.com/newsroom/nearly-half-of-cancer-deaths-attributable-to-modifiable-risk-factors

Panelists Offer an Insider Perspective of the Unstable Future of Genetic Testing Reimbursement: https://www.ajmc.com/conferences/flasco-2019/panelists-offer-an-insider-perspective-of-the-unstable-future-of-genetic-testing-reimbursement

FLASCO Spring Session 2019: https://www.ajmc.com/conferences/flasco-2019

Deaths Among Opioid Users: Impact of Potential Inappropriate Prescribing Practices: https://www.ajmc.com/journals/issue/2019/2019-vol25-n4/deaths-among-opioid-users-impact-of-potential-inappropriate-prescribing-practices

The American Journal of Managed Care—April 2019: https://www.ajmc.com/journals/issue/2019/2019-vol25-n4

Understanding the Impact of Inappropriate Opioid Prescribing Practices by Managed Care Cast

As the prevalence of burnout among healthcare providers has increased over the last few years, it has raised attention to the issue. Burnout includes overwhelming exhaustion, feelings of cynicism and detachment from the job, and a sense of ineffectiveness and a lack of accomplishment. Among physicians, common drivers include excessive workloads, clerical burdens, organizational structures, and leadership culture.

Greater attention to the issue, and the impact it can have on patient outcomes, has led to more organizations to implement interventions to address and alleviate burnout in healthcare. Bernadette Melnyk, PhD, RN, APRN-CNP, FAANP, FNAP, FAAN, vice president for health promotion, chief wellness officer and professor and dean of the college of nursing at The Ohio State University, highlighted the need for a chief wellness officer, same as healthcare has chief technology and quality officers, and some interventions being implemented.

Learn more about burnout:

Making The Case For The Chief Wellness Officer In America’s Health Systems: A Call To Action: https://www.healthaffairs.org/do/10.1377/hblog20181025.308059/full/

Physicians Are Pessimistic About Future of Healthcare, Highlight Extent of Social Determinants: https://www.ajmc.com/focus-of-the-week/physicians-are-pessimistic-about-future-of-healthcare-highlight-extent-of-social-determinants

Physician Burnout Associated With Poorer Patient Outcomes: https://www.ajmc.com/focus-of-the-week/physician-burnout-associated-with-poorer-patient-outcomes

Dr W. Clay Jackson Discusses Identifying, Addressing Clinician Burnout: https://www.ajmc.com/conferences/psychcongress2018/dr-w-clay-jackson-discusses-identifying-addressing-clinician-burnout

Will HHS' Strategy to Address Health IT–Related Physician Burden Provide Relief for Providers? https://www.ajmc.com/focus-of-the-week/will-hhs-strategy-to-address-health-itndashrelated-physician-burden-provide-relief-for-providers

After Increasing for Several Years, Physician Burnout Shows Modest Decline: https://www.ajmc.com/newsroom/after-increasing-for-several-years-physician-burnout-shows-modest-decline

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included CDC clarifying its opioid guidelines for chronic pain; pharmacy benefit managers testifying before a Senate committee; Sanofi expanding its insulin savings program starting in June.

Read more about the stories in this podcast:

Oncologists, Hematologists Welcome CDC Clarification on Opioid Therapy for Chronic Pain: https://www.ajmc.com/newsroom/oncologists-hematologists-welcome-cdc-clarification-on-opioid-therapy-for-chronic-pain

PBM Executives Tout Value Before Senate Finance Committee: https://www.ajmc.com/newsroom/pbm-executives-tout-value-before-senate-finance-committee

Sanofi Offer Sets Monthly Price of $99 for Insulin Supply: https://www.ajmc.com/newsroom/sanofi-offers-set-monthly-price-of-99-for-insulin-supply

Doctors More Likely to Overprescribe Antibiotics for Children During Telemedicine Visits: https://www.ajmc.com/focus-of-the-week/doctors-more-likely-to-overprescribe-antibiotics-for-children-during-telemedicine-visits

Diabetes Management: Advances in Treatment and Management to Reduce Cost and Improve Outcomes: https://www.ajmc.com/meetings/ivbm-la-2019-04-17

As a former chief operating officer for a national diabetes supply, education, and support company, Tom Milam created programs for people with diabetes that served more than 100,000 members nationwide. His experience also includes a federal appointment providing advisory service to Medicare. His extensive experience and knowledge within the diabetes space allows Tom to offer us an expert view of CMS’ Competitive Bidding Program.

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included courts rejecting multiple health initiatives from the Trump administration; Congress heard more about rising insulin prices; a new agreement seeks standards for reporting social determinants of health.

Read more about the stories in this podcast:

Federal Judge Strikes Down Medicaid Work Rules in Kentucky, Arkansas: https://www.ajmc.com/newsroom/federal-judge-strikes-down-medicaid-work-rules-in-kentucky-arkansas

Judge Rules Trump's DOL Tried to Create "End Run" Around ACA With Association Health Plans: https://www.ajmc.com/newsroom/judge-rules-trumps-dol-tried-to-create-end-run-around-aca-with-association-health-plans

Healthcare Availability, Affordability Most Pressing Worry, Gallup Poll Says: https://www.ajmc.com/newsroom/healthcare-availability-affordability-most-pressing-worry-gallup-poll-says

House Subcommittee Hears About Impact of Rising Insulin Prices: https://www.ajmc.com/newsroom/house-subcommittee-hears-about-impact-of-rising-insulin-prices

House Subcommittee Hears Insulin Concerns as FDA Advances Biosimilar Transition: https://www.centerforbiosimilars.com/news/house-subcommittee-hears-insulin-concerns-as-fda-advances-biosimilar-transition

Senate Committee Discusses the Burden of High Drug Prices and Potential Solutions: https://www.ajmc.com/newsroom/senate-committee-discusses-the-burden-of-high-drug-prices-and-potential-solutions

AMA, UnitedHealthcare Announce Collaboration to Better Identify, Address SDOH Through Data: https://www.ajmc.com/newsroom/ama-unitedhealthcare-announce-collaboration-to-better-identify-address-sdoh-through-data

Louisiana Chooses Asegua to Partner for "Netflix" Subscription Model for HCV Treatment: https://www.ajmc.com/focus-of-the-week/louisiana-chooses-asegua-to-partner-for-netflix-subscription-model-for-hcv-treatment

Evidence-Based Diabetes Management—March 2019: https://www.ajmc.com/journals/evidence-based-diabetes-management/2019/march-2019

Three Years After Advocates Report Flaws, Medicare Diabetes Test Strip Bidding Program Nears Collapse: https://www.ajmc.com/journals/evidence-based-diabetes-management/2019/march-2019/three-years-after-advocates-report-flaws-medicare-diabetes-test-strip-bidding-program-nears-collapse

From the Editor-in-Chief: Halt the Glucose Test Strip Bidding Program Until It Can Be Fixed: https://www.ajmc.com/journals/evidence-based-diabetes-management/2019/march-2019/from-the-editorinchief-halt-the-glucose-test-strip-bidding-program-until-it-can-be-fixed